Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+42.86%
Window
Jun 20, 2025 → Jun 8, 2026
Coverage: 244 bars · Jun 20, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Upper Street Marketing Inc. (UPPR) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 42.9% across the available one-year price window (Jun 20, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -225.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -225.0%, free cash flow +24.5% with operating margin -6364.4% and ROIC -11.6%. Valuation is more restrained than many high-expectation growth names at price/sales 2.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UPPR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UPPR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UPPR Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UPPR and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$516.5K
-105.5% YoY
Free Cash Flow
-$824.8K
-116.1% YoY
Revenue Growth
+0.0%
EPS Growth
-225.0%
Gross Margin
-133.7%
Net Margin
-7994.5%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2018 |
|---|---|---|---|---|---|
| Revenue | 185K | 0 | 0 | 0 | 0 |
| Gross Profit | 140K | -36K | -9K | -10K | -17K |
| Operating Income | -177K | -57K | -1M | -1M | -505K |
| EBITDA | -182K | -58K | 170K | 9M | -488K |
| Net Income | -189K | -58K | 161K | 9M | -517K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 36K | 18K | 205 | 13K | 71K |
| Total Assets | 3M | 753K | 885K | 1M | 439K |
| Total Liabilities | 2M | 1M | 2M | 3M | 404K |
| Shareholder Equity | 1M | -458K | -882K | -2M | 35K |
| Total Debt | 916K | 95K | 90K | 90K | 200K |
| Net Debt | 880K | 77K | 90K | 77K | 129K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
792K
-115.4% YoY
Capital Expenditures
32K
-1631.3% YoY
Free Cash Flow
825K
-116.1% YoY
Key ratios
Gross Margin
-133.7%
Operating Margin
-6364.4%
Net Margin
-7994.5%
ROE
-21.8%
Debt / Equity
0.39x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.